我们准备好报销了吗？与卫生技术评估相关的真实世界证据发展综述：第 15 部分。

IF 1.9 4区医学 Q3 HEALTH CARE SCIENCES & SERVICES

Journal of comparative effectiveness research Pub Date : 2024-05-01 Epub Date: 2024-03-28 DOI:10.57264/cer-2024-0033

Alejandra Castanon, Benjamin D Bray, Sreeram V Ramagopalan

{"title":"我们准备好报销了吗？与卫生技术评估相关的真实世界证据发展综述：第 15 部分。","authors":"Alejandra Castanon, Benjamin D Bray, Sreeram V Ramagopalan","doi":"10.57264/cer-2024-0033","DOIUrl":null,"url":null,"abstract":"In this latest update we discuss real-world evidence (RWE) guidance from the leading oncology professional societies, the American Society of Clinical Oncology and the European Society for Medical Oncology, and the PRINCIPLED practical guide on the design and analysis of causal RWE studies.","PeriodicalId":15539,"journal":{"name":"Journal of comparative effectiveness research","volume":" ","pages":"e240033"},"PeriodicalIF":1.9000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037032/pdf/","citationCount":"0","resultStr":"{\"title\":\"R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15.\",\"authors\":\"Alejandra Castanon, Benjamin D Bray, Sreeram V Ramagopalan\",\"doi\":\"10.57264/cer-2024-0033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this latest update we discuss real-world evidence (RWE) guidance from the leading oncology professional societies, the American Society of Clinical Oncology and the European Society for Medical Oncology, and the PRINCIPLED practical guide on the design and analysis of causal RWE studies.\",\"PeriodicalId\":15539,\"journal\":{\"name\":\"Journal of comparative effectiveness research\",\"volume\":\" \",\"pages\":\"e240033\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037032/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of comparative effectiveness research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.57264/cer-2024-0033\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of comparative effectiveness research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.57264/cer-2024-0033","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

摘要

在最新更新的内容中，我们将讨论来自主要肿瘤专业协会、美国临床肿瘤学会和欧洲肿瘤内科学会的真实世界证据 (RWE) 指南，以及关于因果 RWE 研究设计和分析的 PRINCIPLED 实用指南。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15.

In this latest update we discuss real-world evidence (RWE) guidance from the leading oncology professional societies, the American Society of Clinical Oncology and the European Society for Medical Oncology, and the PRINCIPLED practical guide on the design and analysis of causal RWE studies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of comparative effectiveness research HEALTH CARE SCIENCES & SERVICES-

CiteScore

3.50

自引率

9.50%

发文量

121

期刊介绍： Journal of Comparative Effectiveness Research provides a rapid-publication platform for debate, and for the presentation of new findings and research methodologies. Through rigorous evaluation and comprehensive coverage, the Journal of Comparative Effectiveness Research provides stakeholders (including patients, clinicians, healthcare purchasers, and health policy makers) with the key data and opinions to make informed and specific decisions on clinical practice.